reports
- Wedbush Research
MTB M&T BANK CORPORATION
STZ CONSTELLATION BRANDS INC. CLASS A
UBI UBISOFT ENTERTAINMENT SA
DPZ DOMINO'S PIZZA INC.
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PEGA PEGASYSTEMS INC.
MGPI MGP INGREDIENTS INC.
IMAX IMAX CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FHN FIRST HORIZON CORPORATION
EPAM EPAM SYSTEMS INC.
DECK DECKERS OUTDOOR CORPORATION
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
OSTK OVERSTOCK.COM INC.
WD WALKER & DUNLOP INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
AMZN AMAZON.COM INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
TENB TENABLE HOLDINGS
BROS DUTCH BROS INC
Monro, Inc. to Report Fourth Quarter and Year-End Fiscal 2024 Earnings...
ROCHESTER, N.Y.--(BUSINESS WIRE)-- Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2024 fourth quarter and year-end earnings on May 23, 2024. The Company will host a conference call and audio webcast on Thursday, May 23, 2024 at 8:30 a.m. Eastern Time. The conference call may be accessed by dialing 1-833-470-1428 and using the required access code of 167286. A replay will be available approximately two hours after the recording through Thursday, June 6, 2024 and can be accessed by dialing 1-866-813-9403 and using the req...
Xometry Reports First Quarter 2024 Results
Xometry Reports First Quarter 2024 Results Q1 revenue increased 16% year-over-year to $123 million driven by marketplace growth of 24% year-over-year.Q1 gross profit increased 22% year-over-year driven by 37% growth in marketplace gross profit. Q1 marketplace gross margin increased 320 basis points year-over-year to a record 32.0%.Q1 Adjusted EBITDA loss of $7.5 million, a 37% improvement year-over-year driven by higher revenue, gross profit, and operating efficiencies.2024 growth initiatives include: expanding buyer and supplier networks; driving deeper enterprise engagement; expanding the...
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2024. "Our performance in the second quarter and fiscal first half of 2024 underscores the resiliency of our base business, as well as strong operational execution by our global team. Since our spinoff approximately two years ago, we've remained steadfast in delivering on our financial and strateg...
embecta Announces Quarterly Cash Dividend
embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on June 14, 2024 to stockholders of record at the close of business on May 28, 2024. About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions...
Penn Entertainment Inc: 2 directors
Two Directors at Penn Entertainment Inc bought 56,157 shares at between 15.473USD and 15.606USD. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...
Kraft Heinz Co: 1 director
A director at Kraft Heinz Co sold 10,140 shares at 35.952USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
- Jonathan Moreland
RM REGIONAL MANAGEMENT CORP
PENN PENN NATIONAL GAMING INC.
HOO HERBALIFE NUTRITION LTD.
FFIN FIRST FINANCIAL BANKSHARES INC
CNMD CONMED CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
AMH AMERICAN HOMES 4 RENT CLASS A
EFR ENERGY FUELS
MAC MACERICH COMPANY
CTOS CUSTOM TRUCK ONE SOURCE
TBBK INC.
VSTS_w THE BANCORP
EYPT INC.
VESTIS CORPORATION
EYEPOINT PHARMACEUTICALS
INC.
Royal Gold Reports Strong Start to 2024 with Significant Liquidity Inc...
DENVER--(BUSINESS WIRE)-- Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold,” the “Company,” “we,” “us,” or “our”) reports net income of $47.2 million, or $0.72 per share, for the quarter ended March 31, 2024, ("first quarter") on revenue of $148.9 million and operating cash flow of $138.3 million. Adjusted net income1 was $59.8 million, or $0.91 per share. First Quarter 2024 Highlights: Solid financial results with revenue of $148.9 million, operating cash flow of $138.3 million and earnings of $47.2 million Revenue split: 75% gold, 13% silver, 9% copper ...
Anika Announces CFO Transition
Anika Announces CFO Transition Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024 BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has appointed Steve Griffin as the Company’s Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer, effective June 3, 2024. He succeeds Michael Levitz, who has decided to step down as CFO after almost four years with the company. Mr. Levitz will remain with the Company through December 31, 2024, to ensure a sm...
Anika Reports First Quarter 2024 Financial Results
Anika Reports First Quarter 2024 Financial Results Revenue up 7% on growing demand and favorable order timing; On-track for 2024 revenue guidance Cost reduction initiatives complete; On-track to achieve 2024 adjusted EBITDA guidance of $25-30 million, up over 75% at the midpoint BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its first quarter ended March 31, 2024. First Quarter 2024 Financial Summary Revenue in the first quarter of 2024 was $4...
Editas Medicine Announces First Quarter 2024 Results and Business Upda...
Editas Medicine Announces First Quarter 2024 Results and Business Updates Completed adult cohort enrollment and enrolled multiple patients in the adolescent cohort of the Phase 1/2/3 RUBY clinical trial of reni-cel for severe sickle cell disease On track to present additional clinical data from the RUBY trial and the EdiTHAL trial of reni-cel for transfusion-dependent beta-thalassemia in mid-2024 and additional updates by year-end 2024 Presenting pre-clinical data at ASGCT on in vivo capabilities to support development of transformative in vivo gene editing medicines Strong financial pos...
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global He...
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the RBC Capital Markets 2024 Global Healthcare Conference on Wednesday, May 15, 2024, at 1:35 p.m. ET in New York City. A live webcast will be available in the investor section of the company's website at , and will be archived for 60 day...
- Matthew Weiss
- Michael Gerbino
- Scott Devitt
American Express Co: 2 directors
Two Directors at American Express Co sold after exercising options/sold 6,733 shares at between 230.930USD and 232.360USD. The significance rating of the trade was 93/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by al...
American Express Declares Dividend on Series D Preferred Stock and Reg...
NEW YORK--(BUSINESS WIRE)-- The Board of Directors of American Express Company (NYSE: AXP) has declared a quarterly dividend on the Company’s 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, of $9,269.44 per share (which is equivalent to $9.26944 per related Depositary Share). The dividend is payable on June 17, 2024 to shareholders of record on June 1, 2024. The Board also declared a regular quarterly dividend of $0.70 per common share, payable on August 9, 2024, to shareholders of record on July 5, 2024. ABOUT AMERICAN EXPRESS American Express is a globally integrated ...
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; A...
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA Highlights: First quarter revenue of $202 million grew 12% year-over-year, driven by Prenatal (22%), Pharmacogenomics (21%), and Hereditary Cancer (16%). First quarter average revenue per test improved by 2% over the prior year period, reflecting no-pay reduction efforts.First quarter GAAP net loss of $26 million and positive adjusted EBITDA of $4 million; net loss and adjusted EBITDA improve...
United Fire Group, Inc. Reports First Quarter 2024 Results
United Fire Group, Inc. Reports First Quarter 2024 Results First Quarter Net Income of $0.52 per Diluted Share and Adjusted Operating Income of $0.56 per Diluted Share First quarter 2024 highlights: Net income of $13.5 million increased compared to the first quarter of 2023, driven by underwriting income and higher investment income.Net premiums written(1) of $321.3 million increased 17.6% compared to the first quarter of 2023.GAAP combined ratio of 98.9%, including a loss ratio of 64.0% and underwriting expense ratio of 34.9%, improved 4.5 points compared to the first quarter of ...
ALX Oncology Appoints Allison Dillon as Chief Business Officer
ALX Oncology Appoints Allison Dillon as Chief Business Officer SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the appointment of Allison Dillon, Ph.D., as Chief Business Officer (“CBO”). “We are excited to welcome Allison to our leadership team in the midst of this promising growth period for our Company,” said Jason Lettmann, Chief Executive Officer of ALX Oncology. “For over 15 yea...
Myriad Genetics Announces Reorganization of European Operations and Sa...
Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of its European operations to better align company resources to its domestic opportunities while continuing to serve key biopharma partners and patients outside the United States. As part of the reorganization, Myriad signed a definitive agreement to sell its EndoPredict® business to Eurobio Scientific, a leading French group in in vitro med...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.